# miRTarBase 2025: updates to the collection of experimentally validated microRNA–target interactions

*PRI Rank #1 · Topics and Trends in Most Cited MicroRNA in disease regulation Papers, Class of 2026*

*Canonical URL: https://pri.pepkio.com/top-papers/microrna-in-disease-regulation/2026/rank-1*

| Field | Value |
| --- | --- |
| Rank | #1 |
| 18m citations | 178 |
| Journal | Nucleic Acids Research |
| Year | 2024 |
| DOI | 10.1093/nar/gkae1072 |
| Corresponding authors | Liang Wang |
| Institution | The Chinese University of Hong Kong, China |

**Ranking page:** [Topics and Trends in Most Cited MicroRNA in disease regulation Papers, Class of 2026](https://pri.pepkio.com/top-papers/microrna-in-disease-regulation/2026)

**Paper link:** [10.1093/nar/gkae1072](https://doi.org/10.1093/nar/gkae1072)

## Topics

MiRNA-target interactions · miRTarBase · experimentally validated MTIs · miRNA-mRNA networks · miRNA-miRNA networks · drug resistance · predictive biomarkers · safety biomarkers · monitoring biomarkers · toxicity assessment · oxidized miRNA sequences · oxidative modifications · LLAMA3 model · NLP pipeline · prompt engineering · MiRNA-disease association · co-regulatory miRNAs · therapeutic agents · molecular oncology · drug development

## Cite this ranking

```
Pepkio Research Index (PRI). Topics and Trends in Most Cited MicroRNA in disease regulation Papers, Class of 2026. https://pri.pepkio.com/top-papers/microrna-in-disease-regulation/2026. Accessed 2026-07-21.

Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459
```